Grants and Contributions:
Title:
2122-HQ-000005
Agreement Number:
2122-HQ-000005
Agreement Value:
$3,922,683.00
Agreement Date:
Apr 9, 2021 - Mar 31, 2024
Description:
Established the first prescribed alternatives (safer supply) project in Toronto that offered injectable hydromorphone for people with opioid use disorder. The project helped people with opioid use disorder who did not respond to available safer supply and treatment services and who remained at high risk of overdose. The project also helped clients access and remain connected with health, housing, income and community programs that met their specific needs.
Organization:
Health Canada
Expected Results:
Targeted stakeholders and Canadians access evidence-informed information related to substance use and are equipped with the capacity (knowledge, skills and supports) to inform their decisions and actions related to substance use.
Location:
Toronto, Ontario, CA M5V 3C6
Reference Number:
271-2022-2023-Q4-00029
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
867402299
Recipient Type:
Government
Additional Information:
The total agreement value previously disclosed has been updated to reflect an increase resulting from this amendment, and the agreement end date has been updated to reflect an extension.
Amendment Date
Mar 21, 2023
Recipient's Legal Name:
City of Toronto
Program:
Substance Use and Addictions Program
Program Purpose:
Health Protection and Promotion
Amendments: